Echocardiographic Screening for Pulmonary Hypertension in Stable COPD Out-Patients and NT-proBNP as a Rule-Out Test

References

• GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (udpdated 2010). Global initiative for chronic obstructive lung disease (GOLD). 2011; internet page. Available at: http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdf.
   Google Scholar
• Burrows B, Kettel LJ, Niden AH, Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972 Apr;286(17):912–918.
   PubMed Web of Science ®Google Scholar
• Finlay M, Middleton HC, Peake MD, Cardiac output, pulmonary hypertension, hypoxaemia and survival in patients with chronic obstructive airways disease. Eur J Respir Dis 1983 May;64(4):252–263.
   PubMedGoogle Scholar
• Oswald-Mammosser M, Weitzenblum E, Quoix E, Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995 May;107(5):1193–1198.
   PubMed Web of Science ®Google Scholar
• Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979 June;119(6):895–902.
   PubMed Web of Science ®Google Scholar
• Weitzenblum E, Hirth C, Ducolone A, Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981 Oct;36(10):752–758.
   PubMed Web of Science ®Google Scholar
• McGhan R, Radcliff T, Fish R, Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007 Dec;132(6):1748–1755.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Bugnet AS, Kadaoui N, Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005 July;172(2):189–194.
   PubMed Web of Science ®Google Scholar
• Evers H, Liehs F, Harzbecker K, Screening of pulmonary hypertension in chronic obstructive pulmonary disease and silicosis by discriminant functions. Eur Respir J 1992 Apr.;5(4):444–451.
   PubMed Web of Science ®Google Scholar
• Keller CA, Shepard JW, Jr., Chun DS, et al. Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis. Chest 1986 Aug;90(2):185-192.
   PubMed Web of Science ®Google Scholar
• Oswald-Mammosser M, Apprill M, Bachez P, Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration. 1991;58(5–6):304–310.
   PubMed Web of Science ®Google Scholar
• Scharf SM, Iqbal M, Keller C, Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002 Aug;166(3):314–322.
   PubMed Web of Science ®Google Scholar
• Thabut G, Dauriat G, Stern JB, Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005 May;127(5):1531–1536.
   PubMed Web of Science ®Google Scholar
• Cuttica MJ, Kalhan R, Shlobin OA, Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med 2010 June; 104(12):1877–1882.
   PubMed Web of Science ®Google Scholar
• Fayngersh V, Drakopanagiotakis F, Dennis MF, Pulmonary hypertension in a stable community-based COPD population. Lung 2011 Oct;189(5):377–382.
   PubMed Web of Science ®Google Scholar
• Sims MW, Margolis DJ, Localio AR, Impact of pulmonary artery pressure on exercise function in severe COPD. Chest 2009 Aug;136(2):412–419.
   PubMed Web of Science ®Google Scholar
• Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010 June;137(6 Suppl):39S–51S.
   PubMed Web of Science ®Google Scholar
• Forfia PR, Fisher MR, Mathai SC, Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006 Nov;174(9):1034–1041.
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Christie JD, Ferrari VA, Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003 Mar;167(5):735–740.
   PubMed Web of Science ®Google Scholar
• Leuchte HH, Baumgartner RA, Nounou ME, Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006 Apr;173(7):744–750.
   PubMed Web of Science ®Google Scholar
• Leuchte HH, El NM, Tuerpe JC, N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. Chest 2007 Feb;131(2):402–409.
   PubMed Web of Science ®Google Scholar
• Cotes JE, Chinn DJ, Quanjer PH, Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 Mar;1641–1652.
   Google Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 July;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Roberts JD, Forfia PR. Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography. Pulm Circ 2011 Apr;1(2):160–181.
   PubMedGoogle Scholar
• Galiè N, Palazzini M, Manes A. Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. Eur Respir J 2010 Nov.;35(5):986–990.
   Google Scholar
• Lam CS, Borlaug BA, Kane GC, Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 2009 May;119(20):2663–2670.
   PubMed Web of Science ®Google Scholar
• Goetze JP, Videbaek R, Boesgaard S, Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J Heart Lung Transplant 2004 Jan;23(1):80–87.
   PubMed Web of Science ®Google Scholar
• Wieshammer S, Dreyhaupt J, Basler B, NT-proBNP for pulmonologists: not only a rule-out test for systolic heart failure but also a global marker of heart disease. Respiration 2009;77(4):370–380.
   PubMed Web of Science ®Google Scholar
• Balion CM, Santaguida P, McKelvie R Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem 2008 Mar;41(4–5):231–239.
   PubMed Web of Science ®Google Scholar